SCHEMBL7220606

SCHEMBL7220606

Oc1ccc(Oc2cccc3ccccc23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.52
NR1H2 P55055 1/20 0.52
BAX Q07812 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
LMNA P02545 2/20 0.51
MITF O75030 1/20 0.51
POLB P06746 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 2/20 0.49
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.47
SIRT1 Q96EB6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2078871 0.90 L3MBTL1 (0.54) MEN1KMT2ALMNAMITFPOLB
SCHEMBL29243179 0.85 LTA4H (0.48) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL29148791 0.84 L3MBTL1 (0.50) MEN1KMT2ALMNAMITFPOLB
Phenol SCHEMBL15641995 0.84 KDM4E (0.50) MEN1KMT2ALMNAMITFPOLB
SCHEMBL29860318 0.84 KCNA3 (0.58) LTA4HMEN1KMT2ALMNAMITF
SCHEMBL441860 0.84 KCNA3 (0.58) LTA4HMEN1KMT2ALMNAMITF
Water SCHEMBL27705785 0.82 KCNA3 (0.56) LTA4HMEN1KMT2ALMNAMITF
SCHEMBL4244015 0.81 SIRT2 (0.48) MEN1KMT2ALMNAMITFPOLB
SCHEMBL4211500 0.81 LTA4H (0.68) LTA4HNR1H2BAXMEN1KMT2A
SCHEMBL1880664 0.81 L3MBTL1 (0.48) MEN1KMT2ALMNAMITFPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4314108-A1 EPOXY RESIN COMPOSITION, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL Toray Industries, Inc. (JP) 2024-02-07 EP disclosed
CN-106755358-B Method for detecting vibrio parahaemolyticus by combining multi-cross amplification with gold nano biosensing 中国疾病预防控制中心传染病预防控制所 2020-09-01 CN disclosed
CN-107167602-B The methods for intersecting constant-temperature amplification combination gold nano bio-sensing detection comma bacillus more 中国疾病预防控制中心传染病预防控制所 2019-08-02 CN disclosed
CN-107167602-A It is intersect the method that constant-temperature amplification combination gold nano bio-sensing detects comma bacillus more 中国疾病预防控制中心传染病预防控制所 2017-09-15 CN disclosed
CN-106755358-A It is intersect the method that amplification combines gold nano bio-sensing detection vibrio parahemolyticus more 中国疾病预防控制中心传染病预防控制所 2017-05-31 CN disclosed
CN-1918243-B Dried C.I. pigment Red 57:1, dried pigment compositions, and methods for making same DAINIPPON INK & CHEMICALS 2010-05-05 CN disclosed
CN-1918243-A Dried C.I. pigment Red 57:1, dried pigment compositions, and methods for making same DAINIPPON INK & CHEMICALS (JP) 2007-02-21 CN disclosed
US-6573278-B2 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma BAYER AKTIENGESELLSCHAFT (DE) 2003-06-03 US disclosed
EP-0966436-B1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES BAYER AG (DE) 2002-12-11 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
US-6262112-B1 1-(4,4,4-TRIFLUOROBUTYLSULPHONYLOXY)-3-(2-(HYDROXYMETHYL)INDAN -4-YLOXY)-BENZENE BAYER AKTIENGESELLSCHAFT (DE) 2001-07-17 US disclosed
EP-0966436-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES Bayer Aktiengesellschaft (DE) 1999-12-29 EP disclosed
WO-1998037061-A1 ARYL SULFONAMIDES AND ANALOGUES THEREOF AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-08-27 WO disclosed
US-5516767-A PRODRUG AS HYPOGLYCEMIC AGENT SANDOZ LTD. (CH) 1996-05-14 US disclosed
US-5412137-A Hypoglycemic agents SANDOZ LTD. (CH) 1995-05-02 US disclosed
US-4806617-A HEAT RESISTANCE, IMPACT STRENGTH-AIRCRAFT COMPOSITE THE B.F. GOODRICH COMPANY (US) 1989-02-21 US disclosed
EP-0282096-A2 Poly(dinaphthyl arylene ether)and preparation thereof THE B.F. GOODRICH COMPANY (US) 1988-09-14 EP disclosed
US-4391995-A 4-Phenoxy-phenoxy-alkane-carboxylic acid derivatives and process for their manufacture HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-05 US disclosed
US-4301295-A ANTILIPEMIC AND ANTICHOLESTEROL AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-11-17 US disclosed
US-4238626-A ANTICHOLESTEROL AND ANTILIPEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1980-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 LTA4H 1285/4885NR1H2 3722/4885BAX 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.